Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
In a look “Beyond the Guidelines,” a preventive cardiologist and a general internist discuss their approach in the case of a 57-year-old woman with high cholesterol and a family history of heart disease.
Cardiology June 23rd 2022
Annals of Internal Medicine
In a 7-year study of 171,000 individuals with a mean age of 56 years, these researchers elucidate the hazard ratio for death from CVD or cancer and levels of daily coffee consumption.
Cardiology June 7th 2022
A new study published in Annals of Internal Medicine looks at the link between cardiovascular disease among adults with type 2 diabetes, which might be more prevalent than previously thought. This study compares cardiovascular outcomes in patients taking first line metformin vs. SGLT-2 inhibitors, based on claims data over a 7-year period. SGLT-2 inhibitor use was associated with lower rates of hospitalization for heart failure and all cause mortality. Rates for MI and stroke were similar for the two treatments.
Cardiology May 31st 2022
MedPage Today
A report in MedPage Today states that standard heart care is recommended for COVID-19 survivors left with cardiomyopathy and other cardiac conditions, though more answers are needed regarding how long they need to undergo special monitoring, and which groups are at particularly high risk.
Cardiology May 17th 2022
Medtelligence
The lipid metabolism plays an important role in the development of cardiovascular diseases and type 2 diabetes. However, little has been known about the molecular relationships. But now, a set of lipids have been statistically associated with cardiovascular disease and type 2 diabetes.
Cardiology May 3rd 2022
JAMA Network
CVD is the leading cause of death in the US, accounting for more than one in four deaths. Following a systematic review, the US Preventive Services Task Force has provided an update on the effectiveness of aspirin to reduce the risk of CVD events.